Biolase, Inc. (BIOL) Financials

BIOL Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 38.7 million 32.9 million
2023-06-30 39.6 million 32.3 million
2023-03-31 41.9 million 33.8 million
2022-12-31 38.2 million 33.3 million

BIOL Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -2.8 million 275000
2023-06-30 -3.9 million 84000
2023-03-31 -6.2 million 691000
2022-12-31 -6.1 million 612000

BIOL Net Income

No data available :(

BIOL Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 7.8 million - 995000
2023-06-30 6.9 million - 2.1 million
2023-03-31 6.5 million - 2.2 million
2022-12-31 4.2 million - 1.9 million

BIOL Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 1.2 million
2023-06-30 545000
2023-03-31 328060
2022-12-31 77180

BIOL Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 182000 1.4 million 2.7 million 3.4 million
2023-06-30 357000 1.4 million 2.4 million 6.2 million
2023-03-31 587000 1.5 million 2.5 million 4.6 million
2022-12-31 471000 2.1 million 3.5 million 6.5 million

BIOL Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 10.9 million 7.2 million
2023-06-30 14.3 million 8.2 million
2023-03-31 10.5 million 7.1 million
2022-12-31 14.1 million 10.5 million

BIOL

Price: $0.15

52 week price:
0.13
47.00

Earnings Per Share: -29.44 USD

P/E Ratio: -0.01

Exchange: NCM

Sector: Healthcare

Industry: Medical Devices

Volume: 574700

Ebitda: -14.7 million

Market Capitalization: 5.5 million

Average Dividend Frequency: 3

Links: